Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (111-120 of 999) with videos related to

Pageof 100
Sort By:
Plos One|February 26, 2008
Endothelial domes encapsulate adherent neutrophils and minimize increases in vascular permeability in paracellular and transcellular emigrationMia Phillipson, Jaswinder Kaur, Pina Colarusso, et al.
Atherosclerosis|September 7, 2015
Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) StudySahiti Bhaskara, Eric A Whitsel, Christie M Ballantyne, et al.
The American Journal of Clinical Nutrition|June 11, 2008
Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities StudyKelly A Volcik, Jennifer A Nettleton, Christie M Ballantyne, et al.
Blood|August 1, 1992
Molecular cloning and analysis of in vivo expression of murine P-selectinW E Sanders, R W Wilson, C M Ballantyne, et al.
Journal of Immigrant and Minority Health|November 21, 2007
Prevalence of metabolic syndrome and associated risk factors in Asian IndiansAjay Balasubramanyam, Shaun Rao, Ranjita Misra, et al.
American Heart Journal|May 3, 2005
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) studyChristie M Ballantyne, Nicola Abate, Zhong Yuan, et al.
Regulatory Toxicology and Pharmacology : RTP|December 11, 2012
The effect of long term storage on tobacco smoke particulate matter in in vitro genotoxicity and cytotoxicity assaysI Crooks, D M Dillon, J K Scott, et al.
Cardiovascular Drugs and Therapy|September 30, 2020
Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies-a Clinical PerspectiveXiaoming Jia, Jing Liu, Anurag Mehta, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2018
Critical role of integrin CD11c in splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunityJiaxi Wu, Huaizhu Wu, Jinping An, et al.
Atherosclerosis|February 13, 2026
The evolving therapeutic landscape of PCSK9 inhibitionBrett S Mansfield, Yakubu Bene-Alhasan, Christie M Ballantyne, et al.
Pageof 100

Showing results (111-120 of 999) with videos related to

Sort By:
Pageof 100
Plos One|February 26, 2008
Endothelial domes encapsulate adherent neutrophils and minimize increases in vascular permeability in paracellular and transcellular emigrationMia Phillipson, Jaswinder Kaur, Pina Colarusso, et al.
Atherosclerosis|September 7, 2015
Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) StudySahiti Bhaskara, Eric A Whitsel, Christie M Ballantyne, et al.
The American Journal of Clinical Nutrition|June 11, 2008
Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities StudyKelly A Volcik, Jennifer A Nettleton, Christie M Ballantyne, et al.
Blood|August 1, 1992
Molecular cloning and analysis of in vivo expression of murine P-selectinW E Sanders, R W Wilson, C M Ballantyne, et al.
Journal of Immigrant and Minority Health|November 21, 2007
Prevalence of metabolic syndrome and associated risk factors in Asian IndiansAjay Balasubramanyam, Shaun Rao, Ranjita Misra, et al.
American Heart Journal|May 3, 2005
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) studyChristie M Ballantyne, Nicola Abate, Zhong Yuan, et al.
Regulatory Toxicology and Pharmacology : RTP|December 11, 2012
The effect of long term storage on tobacco smoke particulate matter in in vitro genotoxicity and cytotoxicity assaysI Crooks, D M Dillon, J K Scott, et al.
Cardiovascular Drugs and Therapy|September 30, 2020
Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies-a Clinical PerspectiveXiaoming Jia, Jing Liu, Anurag Mehta, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2018
Critical role of integrin CD11c in splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunityJiaxi Wu, Huaizhu Wu, Jinping An, et al.
Atherosclerosis|February 13, 2026
The evolving therapeutic landscape of PCSK9 inhibitionBrett S Mansfield, Yakubu Bene-Alhasan, Christie M Ballantyne, et al.
Pageof 100